Optimizing GWG in Obese Pregnant Women: A Nationwide Real-World Study Using the U.S. Natality Cohort | MicrobiomeTrials← Back to trialsNCT07796815
Optimizing GWG in Obese Pregnant Women: A Nationwide Real-World Study Using the U.S. Natality Cohort
CompletedOBSERVATIONAL
Trial Details
Start: 2023-01-01Est. Completion: 2025-12-31
Enrollment target: 1,600,000 participants Locations- National Vital Statistics System (NVSS) - United States, Hyattsville, Maryland, United States
Other microbiome trials you might be interested in
Grade 1 Endometrial Endometrioid CarcinomaEndometrial Intraepithelial NeoplasiaMetabolic Comorbidities
This single-arm study will evaluate the feasibility, safety, and preliminary efficacy of tirzepatide in combination with…
Hershey, United StatesEst. completion May 1, 2028
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance
To investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-…
Shanghai, China
Est. completion Mar 30, 2028
TirzepatideFrozen Embryo TransferObesity
To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese wo…
Shanghai, ChinaEst. completion Dec 2029